## Pymaceuticals SCC Tumor Study Analysis
### Overview
Pymaceuticals, Inc., a pharmaceutical company specializing in anti-cancer medications, has conducted a comprehensive study to evaluate the efficacy of various drug regimens on squamous cell carcinoma (SCC) tumors. This study involves 249 mice with SCC tumors, treated with different drug regimens over a period of 45 days. The primary objective is to assess and compare the performance of Pymaceuticalsâ€™ drug, Capomulin, with other treatments.

## Objective
The primary goal of this analysis is to generate tables and figures to include in the technical report and provide a summary of the study results. This analysis will help in understanding the effectiveness of Capomulin compared to other treatment regimens.
